Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer. Felip E, Metro G, Soo RA, Wolf J, et al. Eur J Cancer 2024;208:114182.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Felip E, Metro G, Soo RA, Wolf J, et al. Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer. Eur J Cancer 2024;208:114182.
PMID: 38986421